Z. Wang

发表

Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination

M. Lehtinen, J. Dillner, J. Schiller, 2000, Sexually transmitted infections.

Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.

J. Dillner, J. Schiller, E. Åvall-Lundqvist, 1999, The Journal of general virology.

Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: a population-based case-control study.

F. Wiklund, J. Dillner, G. Hallmans, 1999, The Journal of general virology.

Type specificity and significance of different isotypes of serum antibodies to human papillomavirus capsids.

F. Wiklund, M. Lehtinen, J. Dillner, 2000, The Journal of infectious diseases.

Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA

J. Dillner, J. Schiller, M. Sapp, 1996, Journal of clinical microbiology.

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera.

J. Dillner, J. Schiller, N. Christensen, 1997, The Journal of general virology.

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

R. Karron, B. Murphy, D. Lowy, 2001, Journal of the National Cancer Institute.

Stability over time of serum antibody levels to human papillomavirus type 16.

M. Lehtinen, J. Dillner, J. Schiller, 1998, The Journal of infectious diseases.

Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden.

J. Dillner, R. Bergström, O. Nyrén, 1999, Journal of the National Cancer Institute.

A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway.

T. Bjørge, M. Lehtinen, J. Dillner, 1997, Cancer research.